Aug 24, 2025, 12:40
Understanding Leptomeningeal Metastatic Disease – WeTrials
WeTrials shared a post on LinkedIn:
“Understanding Leptomeningeal Metastatic Disease (LMD)
In this video, Dr. Alireza Mansouri’s AI avatar explains how LMD develops, how it’s diagnosed, and the promising treatments and clinical trials shaping care in 2025.
At WeTrials, we believe knowledge and access can change outcomes. That’s why we’ve built the Clinical Trial Finder—to help patients and caregivers explore treatment options and ongoing research with ease.
Watch the video.
Scan the QR code at the end to explore trials personalized to you.
Feeling stuck?
Explore the resources, find community, and take empowered next steps.”
More posts featuring WeTrials on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 24, 2025, 12:40
Aug 24, 2025, 12:35
Aug 24, 2025, 12:33
Aug 24, 2025, 12:08
Aug 24, 2025, 11:58
Aug 24, 2025, 11:46
Aug 24, 2025, 11:32
Aug 24, 2025, 11:25
Aug 24, 2025, 11:24
Aug 24, 2025, 10:59